Şunu aradınız:: disease risks (İngilizce - Hırvatça)

disease
bolest

liver disease
bolest jetre

reflux disease,
gastroezofagealni refluks,

heartworm disease:
bolest srčanog crva:

basedow’s disease
basedowljeva bolest

addison’s disease)
addisonovu bolest)

diseases / procedures with special haemorrhagic risks
bolesti / postupci s posebnim rizicima od krvarenja

hepatic steatosis and risk of progressive liver disease
hepatička steatoza i rizik od progresivne bolesti jetre

there is also a potential risk of autoimmune disease.
postoji i mogući rizik od autoimune bolesti.

thyroid disease (see section 4.4 thyroid disorders) poses special risks in women who are pregnant.
bolest štitnjače (vidjeti dio 4.4 poremećaji štitnjače) predstavlja poseban rizik za trudnice.

hepatic disease associated with coagulopathy and clinically relevant bleeding risk.
bolesnici s bolešću jetre udruženom s koagulopatijom i klinički značajnim rizikom od krvarenja.

educate patients about chronic liver disease and the risk of thromboembolic events.
bolesnike treba educirati o kroničnoj bolesti jetre i riziku tromboembolijskih događaja.

if you are at risk of blood clots. if you have severe kidney disease.
ako imate rizik za nastanak krvnih ugrušaka ako imate tešku bolest bubrega.

reversing dabigatran therapy exposes patients to the thrombotic risk of their underlying disease.
poništenje terapije dabigatranom izlaže bolesnike riziku od tromboze u njihovoj osnovnoj bolesti ili stanju.

they are lately more and more connected to the increase of heart and blood system disease risk .
u posljednje vrijeme sve više ih se povezuje sa povećanjem rizika od bolesti srca i krvožilnog sustava .

caution should be used when treating patients at higher cardiovascular risk including known coronary artery disease.
nužan je oprez u liječenju bolesnika s višim kardiovaskularnim rizikom uključujući poznatu koronarnu arterijsku bolest.

a risk for transmission of creutzfeld-jacob disease (cjd) cannot be excluded.
rizik od prijenosa creutzfeld-jacobove bolesti (cjd) ne može se isključiti.

a risk of transmission of creutzfeld-jacob disease (cjd) cannot be ruled out.
rizik od prijenosa creutzfeld-jacobove bolesti (cjd) ne može se isključiti.

hepatic disease associated with coagulopathy and clinically relevant bleeding risk (see section 5.2).
bolest jetre udružena s koagulopatijom i klinički značajnim rizikom od krvarenja (vidjeti dio 5.2)

yellow fever vaccine: risk of fatal generalised vaccinale disease (see section 4.3).
cjepivo protiv žute groznice: rizik od smrtonosne generalizirane vakcinalne bolesti (vidjeti dio 4.3).